kenvue - Search News

Order byBest matchMost fresh

Kenvue, CEO Thibaut Mongon

Tylenol maker Kenvue ousts CEO amid board's strategic review

By Sriparna Roy and Abigail Summerville (Reuters) -Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the entire company or pieces of it.

Cosmetics Business · 4h

Kenvue ousts CEO and launches strategic review amid struggling sales

Fierce Pharma · 1h

Consumer health giant Kenvue kicks off CEO transition as sales slip

· 1d

Kenvue CEO Mongon Stepping Down as Company Continues With Strategic Review

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company.

· 1d

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood

· 1d

Kenvue Seeks Its Own Band-Aid With CEO Departure and Strategic Review. The Stock Rises.

· 5h

Kenvue: New CEO, Watch The Dividend (Rating Downgrade)

High debt load and rising rates strain Kenvue’s free cash flow and dividend sustainability.

SchaeffersResearch.com · 1d

Call Traders Circle Tylenol Parent Amid C-Suite Swap

· 1d

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29

Barchart on MSN20h

Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?

Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to $27.

Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut

Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors

Two years ago, when Johnson & Johnson announced it was spinning off its consumer brands including Tylenol, Band-Aid, Motrin, Sudafed, and Neutrogena into a new company called Kenvue, investor anticipation was high.

Stock Movers: Coinbase, Kenvue, Synopsis

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Explore more